用于治疗膀胱过度活动症症状的抗胆碱能药物综述。 - Suppr

Suppr

超能文献

A review of anticholinergic medications for overactive bladder symptoms.

作者信息

Felicilda-Reynaldo Rhea Faye

机构信息

Department of Nursing, Missouri State University, Springfield, MO, USA.

出版信息

Medsurg Nurs. 2013 Mar-Apr;22(2):119-23.

PMID:23802499

Abstract

摘要

相似文献

A review of anticholinergic medications for overactive bladder symptoms.

Medsurg Nurs. 2013 Mar-Apr;22(2):119-23.

Pharmacologic management of overactive bladder.

Clin Interv Aging. 2007;2(3):337-45.

Efficacy and tolerability of solifenacin in patients aged ≥ 65 years with overactive bladder: post-hoc analysis of 2 open-label studies.

Postgrad Med. 2011 Jan;123(1):94-104. doi: 10.3810/pgm.2011.01.2250.

Update on drugs for overactive bladder syndrome.

Drug Ther Bull. 2007 Jun;45(6):44-8. doi: 10.1136/dtb.2007.45644.

[Overactive bladder. New anticholinergic drug controls urinary urge].

MMW Fortschr Med. 2004 Jul 8;146(27-28):51.

Pediatrics: combining antimuscarinics shows promise for overactive bladder.

Nat Rev Urol. 2010 Feb;7(2):66-8. doi: 10.1038/nrurol.2010.1.

[Comparisons of efficacy and safety of tolterodine and oxybutynin in children with idiopathic overactive bladder].

Zhongguo Dang Dai Er Ke Za Zhi. 2011 Jan;13(1):26-8.

Editorial comment.

J Urol. 2009 Oct;182(4 Suppl):2038-9; discussion 2039. doi: 10.1016/j.juro.2009.05.162. Epub 2009 Aug 20.

Editorial comment.

J Urol. 2009 Oct;182(4 Suppl):2038; discussion 2039. doi: 10.1016/j.juro.2009.05.161. Epub 2009 Aug 20.

Editorial comment.

J Urol. 2009 Oct;182(4 Suppl):2038; discussion 2039. doi: 10.1016/j.juro.2009.05.160. Epub 2009 Aug 20.

引用本文的文献

Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients.

Asian J Urol. 2022 Jan;9(1):42-50. doi: 10.1016/j.ajur.2021.04.002. Epub 2021 Apr 20.

Comparison of objective and subjective factors in the adherence to antimuscarinics when treating overactive bladder in employed persons.

Ther Adv Urol. 2017 Oct 5;9(12):271-279. doi: 10.1177/1756287217731010. eCollection 2017 Dec.

A new tool for self-evaluation of adherence to antimuscarinic drugs treatment in patients with urinary incontinence.

Arab J Urol. 2017 Nov 16;15(4):372-379. doi: 10.1016/j.aju.2017.10.007. eCollection 2017 Dec.

Long-term adherence to antimuscarinic drugs when treating overactive bladder in the older: Subjective reason and objective factors.

Investig Clin Urol. 2017 Mar;58(2):109-116. doi: 10.4111/icu.2017.58.2.109. Epub 2017 Feb 1.

Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial.

Ther Adv Urol. 2016 Aug;8(4):239-248. doi: 10.1177/1756287216652030. Epub 2016 Jun 3.

A short review of drug-food interactions of medicines treating overactive bladder syndrome.

Int J Clin Pharm. 2016 Dec;38(6):1350-1356. doi: 10.1007/s11096-016-0383-5. Epub 2016 Oct 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A review of anticholinergic medications for overactive bladder symptoms.

Medsurg Nurs. 2013 Mar-Apr;22(2):119-23.

Pharmacologic management of overactive bladder.

Clin Interv Aging. 2007;2(3):337-45.

Efficacy and tolerability of solifenacin in patients aged ≥ 65 years with overactive bladder: post-hoc analysis of 2 open-label studies.

Postgrad Med. 2011 Jan;123(1):94-104. doi: 10.3810/pgm.2011.01.2250.

Update on drugs for overactive bladder syndrome.

Drug Ther Bull. 2007 Jun;45(6):44-8. doi: 10.1136/dtb.2007.45644.

[Overactive bladder. New anticholinergic drug controls urinary urge].

MMW Fortschr Med. 2004 Jul 8;146(27-28):51.

Pediatrics: combining antimuscarinics shows promise for overactive bladder.

Nat Rev Urol. 2010 Feb;7(2):66-8. doi: 10.1038/nrurol.2010.1.

[Comparisons of efficacy and safety of tolterodine and oxybutynin in children with idiopathic overactive bladder].

Zhongguo Dang Dai Er Ke Za Zhi. 2011 Jan;13(1):26-8.

Editorial comment.

J Urol. 2009 Oct;182(4 Suppl):2038-9; discussion 2039. doi: 10.1016/j.juro.2009.05.162. Epub 2009 Aug 20.

Editorial comment.

J Urol. 2009 Oct;182(4 Suppl):2038; discussion 2039. doi: 10.1016/j.juro.2009.05.161. Epub 2009 Aug 20.

Editorial comment.

J Urol. 2009 Oct;182(4 Suppl):2038; discussion 2039. doi: 10.1016/j.juro.2009.05.160. Epub 2009 Aug 20.

引用本文的文献

Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients.

Asian J Urol. 2022 Jan;9(1):42-50. doi: 10.1016/j.ajur.2021.04.002. Epub 2021 Apr 20.

Comparison of objective and subjective factors in the adherence to antimuscarinics when treating overactive bladder in employed persons.

Ther Adv Urol. 2017 Oct 5;9(12):271-279. doi: 10.1177/1756287217731010. eCollection 2017 Dec.

A new tool for self-evaluation of adherence to antimuscarinic drugs treatment in patients with urinary incontinence.

Arab J Urol. 2017 Nov 16;15(4):372-379. doi: 10.1016/j.aju.2017.10.007. eCollection 2017 Dec.

Long-term adherence to antimuscarinic drugs when treating overactive bladder in the older: Subjective reason and objective factors.

Investig Clin Urol. 2017 Mar;58(2):109-116. doi: 10.4111/icu.2017.58.2.109. Epub 2017 Feb 1.

Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial.

Ther Adv Urol. 2016 Aug;8(4):239-248. doi: 10.1177/1756287216652030. Epub 2016 Jun 3.

A short review of drug-food interactions of medicines treating overactive bladder syndrome.

Int J Clin Pharm. 2016 Dec;38(6):1350-1356. doi: 10.1007/s11096-016-0383-5. Epub 2016 Oct 13.